Synergistic antitumor effects of combination PI3K/mTOR and MEK inhibition (SAR245409 and pimasertib) in ovarian carcinoma cells by fluorescence resonance energy transfer imaging
Two pathogenetic types of endometrial carcinoma
Apoptosis-targeted therapies for cancer
High Frequency of Coexistent Mutations of
<i>PIK3CA</i>
and
<i>PTEN</i>
Genes in Endometrial Carcinoma
Inhibition of estrogen receptor alpha expression and function in MCF‐7 cells by kaempferol
Kaempferol Inhibits Angiogenesis and VEGF Expression Through Both HIF Dependent and Independent Pathways in Human Ovarian Cancer Cells
Rapid Estrogen Signaling Negatively Regulates PTEN Activity Through Phosphorylation in Endometrial Cancer Cells
Establishment and Characterization of Human Endometrial Cancer Cell Lines
Estrogen Receptor α Inhibits p53-Mediated Transcriptional Repression: Implications for the Regulation of Apoptosis
Kaempferol induces apoptosis in ovarian cancer cells through activating p53 in the intrinsic pathway
Significance of survivin as a prognostic factor and a therapeutic target in endometrial cancer
Autophagy inhibition augments resveratrol-induced apoptosis in Ishikawa endometrial cancer cells
Resistance to chemotherapy and hormone therapy in endometrial cancer
Activation of PI3K/Akt/mTOR Pathway and Dual Inhibitors of PI3K and mTOR in Endometrial Cancer
Survivin: Key Regulator of Mitosis and Apoptosis and Novel Target for Cancer Therapeutics
Transcriptional Repression of the Anti-apoptoticsurvivin Gene by Wild Type p53
Kaempferol induces apoptosis in human HCT116 colon cancer cells via the Ataxia-Telangiectasia Mutated-p53 pathway with the involvement of p53 Upregulated Modulator of Apoptosis
Targeted cancer therapy
Lack of toxicity of therapy-induced T cell responses against the universal tumour antigen survivin
Kaempferol suppresses cell metastasis via inhibition of the ERK-p38-JNK and AP-1 signaling pathways in U-2 OS human osteosarcoma cells
Expression of survivin, PTEN and p27 in normal, hyperplastic, and carcinomatous endometrium
Targeting survivin in cancer
Stem cells, cancer, and cancer stem cells
Autologous Dendritic Cell Vaccines for Non–Small-Cell Lung Cancer
Common genetic variation in the sex hormone metabolic pathway and endometrial cancer risk: pathway-based evaluation of candidate genes
Expression of NgBR Is Highly Associated with Estrogen Receptor Alpha and Survivin in Breast Cancer
Survivin: A Bifunctional Inhibitor of Apoptosis Protein
Heregulin-β1 regulates the estrogen receptor-α gene expression and activity via the ErbB2/PI 3-K/Akt pathway
Survivin: A molecular biomarker in cancer
Estradiol and testosterone levels in the peripheral and ovarian circulations in patients with endometrial cancer
Kaempferol induces ATM/p53-mediated death receptor and mitochondrial apoptosis in human umbilical vein endothelial cells
Translocation of cytoplasmic estrogen receptors to the nucleus: Immunohistochemical demonstration utilizing rabbit antibodies to estrogen receptors of mammary carcinomas
Pathological findings and prognosis from uterine malignancy
Anti-cancer Effect and Underlying Mechanism(s) of Kaempferol, a Phytoestrogen, on the Regulation of Apoptosis in Diverse Cancer Cell Models
Survivin: A new target for anti-cancer therapy
Surgical management and postoperative treatment of endometrial carcinoma